picolinamide has been researched along with ruthenium in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amaresekera, T; Clarkson, GJ; Deeth, RJ; Hebden, AJ; McGowan, PC; Parsons, S; Sadler, PJ; van Rijt, SH | 1 |
| Almodares, Z; Basri, AM; Crossley, BD; Hebden, AJ; Lucas, SJ; McGowan, PC; Pask, CM; Phillips, RM | 1 |
2 other study(ies) available for picolinamide and ruthenium
| Article | Year |
|---|---|
Amide linkage isomerism as an activity switch for organometallic osmium and ruthenium anticancer complexes.
Topics: Adenine; Amides; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; DNA; Guanine; Humans; Hydrogen-Ion Concentration; Hydrolysis; Isomerism; Kinetics; Ligands; Magnetic Resonance Spectroscopy; Models, Molecular; Molecular Conformation; Organometallic Compounds; Osmium; Picolinic Acids; Quantum Theory; Ruthenium; Thermodynamics | 2009 |
Rhodium, iridium, and ruthenium half-sandwich picolinamide complexes as anticancer agents.
Topics: Amides; Antineoplastic Agents; Cell Hypoxia; HT29 Cells; Humans; Inhibitory Concentration 50; Iridium; MCF-7 Cells; Organometallic Compounds; Picolinic Acids; Rhodium; Ruthenium | 2014 |